TP53 and breast cancer: Tumor types including breast cancer, colorectal and thyroid derive their metastatic potential from cadherins, TP53 loss, and other proteolytic enzymes and soluble molecules involved in tumor epigenetics, which may help in them crossing barricaded BBB defenses through the endothelial cell layer of brain capillaries and vessels (10).